Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
出版年份 2010 全文链接
标题
Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
作者
关键词
-
出版物
PLoS One
Volume 5, Issue 8, Pages e12395
出版商
Public Library of Science (PLoS)
发表日期
2010-08-25
DOI
10.1371/journal.pone.0012395
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Attenuated poxvirus vectors MVA and NYVAC as promising vaccine cadidates against HIV/AIDS
- (2014) Mariano Esteban Human vaccines & immunotherapeutics
- Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
- (2010) José Luis Nájera et al. PLoS One
- Use of Nonhuman Primate Models to Develop Mucosal AIDS Vaccines
- (2010) Meritxell Genescà et al. Current HIV/AIDS Reports
- The Interferon System and Vaccinia Virus Evasion Mechanisms
- (2009) Beatriz Perdiguero et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens
- (2009) P. Mooij et al. JOURNAL OF VIROLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens
- (2009) Carmen E. Gómez et al. VACCINE
- Preclinical Evaluation of the Immunogenicity of C-Type HIV-1-Based DNA and NYVAC Vaccines in the Balb/C Mouse Model
- (2009) Jens Wild et al. VIRAL IMMUNOLOGY
- The Poxvirus Vectors MVA and NYVAC as Gene Delivery Systems for Vaccination Against Infectious Diseases and Cancer
- (2008) Carmen Gomez et al. CURRENT GENE THERAPY
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
- (2008) Alexandre Harari et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Differential CD4+ versus CD8+ T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide Comparable Efficacies in Primates
- (2008) P. Mooij et al. JOURNAL OF VIROLOGY
- Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
- (2008) Matthew G. Cottingham et al. PLoS One
- Structure and Function of A41, a Vaccinia Virus Chemokine Binding Protein
- (2008) Mohammad W. Bahar et al. PLoS Pathogens
- EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
- (2008) Sheena McCormack et al. VACCINE
- Vaccinia Virus E3 Protein Prevents the Antiviral Action of ISG15
- (2008) Susana Guerra et al. PLoS Pathogens
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started